Get started
Author

Daniel Gilbert Weber

Observed names: D Weber, D. G. Weber, D. Weber, D.G. Weber, Daniel G Weber, Daniel G. Weber, Daniel Weber, Weber, Daniel, Weber, Daniel G., Weber, Daniel Gilbert
ORCID: 0000-0001-9009-8387
Observed ORCID: 0000-0001-9009-8387
OpenAlex ID: A5029380251
Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer
2013 · Daniel Gilbert Weber, Georg Johnen, et al. · BMC Research Notes · 198
PDF
Identification of miRNA-103 in the Cellular Fraction of Human Peripheral Blood as a Potential Biomarker for Malignant Mesothelioma – A Pilot Study
2012 · Daniel G. Weber, Georg Johnen, et al. · PLoS ONE · 89
PDF
Assessment of mRNA and microRNA Stabilization in Peripheral Human Blood for Multicenter Studies and Biobanks
2010 · Daniel Gilbert Weber, Swaantje Casjens, et al. · Biomarker Insights · 86
PDF
Biomarker research with prospective study designs for the early detection of cancer
2013 · B. Pesch, T. Brüning, et al. · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · 60
Circulating miR-132-3p as a Candidate Diagnostic Biomarker for Malignant Mesothelioma
2017 · Daniel G. Weber, Katarzyna Gawrych, et al. · Disease Markers · 58
PDF
Combination of MiR-103a-3p and Mesothelin Improves the Biomarker Performance of Malignant Mesothelioma Diagnosis
2014 · Daniel G. Weber, Swaantje Casjens, et al. · PLoS ONE · 56
PDF
Prediagnostic detection of mesothelioma by circulating calretinin and mesothelin – a case-control comparison nested into a prospective cohort of asbestos-exposed workers
2018 · Georg Johnen, Katarzyna Burek, et al. · Scientific Reports · 53
PDF
Calretinin as a blood-based biomarker for mesothelioma
2017 · Georg Johnen, Katarzyna Gawrych, et al. · BMC Cancer · 47
PDF
Performance of biomarkers SMRP, CA125, and CYFRA 21-1 as potential tumor markers for malignant mesothelioma and lung cancer in a cohort of workers formerly exposed to asbestos
2010 · M. Gube, D. Taeger, et al. · Archives of Toxicology · 46
Cancer mortality in a surveillance cohort of German males formerly exposed to asbestos
2009 · Beate Pesch, Dirk Taeger, et al. · International Journal of Hygiene and Environmental Health · 42
Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients
2010 · Irina Raiko, Ingrid Sander, et al. · BMC Cancer · 41
PDF
Are circulating microRNAs suitable for the early detection of malignant mesothelioma? Results from a nested case–control study
2019 · the MoMar study group, Daniel Gilbert Weber, et al. · BMC Research Notes · 32
PDF
Mesothelin, Calretinin, and Megakaryocyte Potentiating Factor as Biomarkers of Malignant Pleural Mesothelioma
2019 · Carmina Jiménez-Ramírez, Swaantje Casjens, et al. · Lung · 28
Soluble mesothelin-related peptides (SMRP) – High stability of a potential tumor marker for mesothelioma
2007 · Daniel G. Weber, Dirk Taeger, et al. · Cancer Biomarkers · 28
Kinetics of chemotaxis, cytokine, and chemokine release of NR8383 macrophages after exposure to inflammatory and inert granular insoluble particles
2016 · I. Schremmer, A. Brik, et al. · Toxicology Letters · 26
Assessment of Confounding Factors Affecting the Tumor Markers SMRP, CA125, and CYFRA21-1 in Serum
2010 · Daniel Gilbert Weber, Georg Johnen, et al. · Biomarker Insights · 26
PDF
Biomarkers for Predicting Malignant Pleural Mesothelioma in a Mexican Population
2018 · Guadalupe Aguilar-Madrid, Beate Pesch, et al. · International Journal of Medical Sciences · 22
PDF
Lung cancer and mesothelioma risks in a prospective cohort of workers with asbestos‐related lung or pleural diseases
2022 · Dirk Taeger, Katharina Wichert, et al. · American Journal of Industrial Medicine · 21
PDF
Multi-walled carbon nanotubes induce stronger migration of inflammatory cells in vitro than asbestos or granular particles but a similar pattern of inflammatory mediators
2019 · Götz A. Westphal, Nina Rosenkranz, et al. · Toxicology in Vitro · 21
PDF
Assessment of potential predictors of calretinin and mesothelin to improve the diagnostic performance to detect malignant mesothelioma: results from a population-based cohort study
2017 · Swaantje Casjens, Daniel G Weber, et al. · BMJ Open · 20
PDF
Circulating long non-coding RNA GAS5 (growth arrest-specific transcript 5) as a complement marker for the detection of malignant mesothelioma using liquid biopsies
2020 · the MoMar study group, Daniel G. Weber, et al. · Biomarker Research · 19
PDF
Cross-Contamination of a UROtsa Stock with T24 Cells – Molecular Comparison of Different Cell Lines and Stocks
2013 · Georg Johnen, Peter Rozynek, et al. · PLoS ONE · 17
PDF
Blood‐based detection of lung cancer using cysteine‐rich angiogenic inducer 61 (CYR61) as a circulating protein biomarker: a pilot study
2021 · Lucija Ačkar, Swaantje Casjens, et al. · Molecular Oncology · 15
PDF
Intracellular, time-resolved speciation and quantification of arsenic compounds in human urothelial and hepatoma cells
2011 · Joerg Hippler, Ricarda Zdrenka, et al. · Journal of Analytical Atomic Spectrometry · 15
Re-evaluation of potential predictors of calretinin and mesothelin in a population-based cohort study using assays for the routine application in clinical medicine
2021 · Swaantje Casjens, Georg Johnen, et al. · BMJ Open · 11
PDF
Works count: 56
Citation count: 1,122
H-index: 20
I10-index: 26
Year
Topic
Type